Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
2037025-98-0
1220017-20-8
1236266-87-7
301840-56-2
786630-75-9
890023-08-2
13551-74-1 | 5-Chloro-1-ethyl-3-methyl-4-nitro-1h-pyrazole | AA019SS0 | MFCD21667720
331826-46-1 | 1-(ethylsulfanyl)propan-2-amine | AA019SWV | MFCD19213746
1260823-98-0 | 2-(piperidin-4-yl)-5-(trifluoromethyl)aniline | AA019T2C | MFCD17486505
1250290-30-2 | 1-[4-(pyrimidin-5-yl)phenyl]ethan-1-amine | AA019T6N | MFCD16829946
1375473-81-6 | 2-[4-(trifluoromethyl)phenyl]cyclohexan-1-amine | AA019TCX | MFCD17536170
104278-45-7 | 2-phenyl-4H,5H,6H,7H-furo[2,3-c]pyridine hydrochloride | AA019THH | MFCD21602661
946727-50-0 | 3-(ethoxymethyl)pyrrolidine | AA019TLJ | MFCD08687713
1375471-99-0 | 1-[(1-methyl-1H-imidazol-2-yl)methyl]piperidine-4-carboxylic acid dihydrochloride | AA019TPO | MFCD21602752
1376324-18-3 | 2-(azetidin-3-yloxy)-N,N-dimethylacetamide hydrochloride | AA019TVJ | MFCD22056491
1006538-98-2 | 4-bromo-1-{[3-(trifluoromethyl)phenyl]methyl}-1H-pyrazole | AA019TZM | MFCD02828766
Journal: Bioorganic & medicinal chemistry letters20101101